Amalyte Pharmaceuticals Overview
- Founded
-
2006
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Amalyte Pharmaceuticals General Information
Description
Operator of a clinical stage bio pharmaceutical company intended to serve the healthcare sector. The company is focused on identifying and developing novel therapies for the treatment of immune and inflammatory diseases.
Contact Information
Website
www.amalyte.kemin.com
Formerly Known As
Amalyte Pharmaceuticals, Inc.
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- 548 Market Street
- San Francisco, CA 94104
- United States
Amalyte Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|